Kaposi's sarcoma (KS) was first described by Moritz Kaposi in 1872. Four forms exist -classic KS, African/ endemic KS, AIDS-related KS and transplant-related KS.
Although regarded as a neoplasm, KS is not a typical cancer. It is typically multifocal, it may regress with immune restoration, and the lesional cells are dependent on exogenous growth signals in vitro. [1] Human herpesvirus 8 (HHV8) has been linked to KS. KS occurs most frequently in mucocutaneous sites. However, lymph nodes, visceral organs and unusual sites such as bone may also be involved. [3] Patients may present with minimal or disseminated disease. Clinically, early skin and mucosal lesions may be difficult to recognise as they appear as faint, red-brown to violet macules. The established lesions of KS present as violaceous papules, plaques or nodules. Patients who have bronchopulmonary KS usually present with respiratory symptoms such as cough and breathlessness, while patients with gastrointestinal tract (GIT) KS may present with abdominal pain, nausea, weight loss, GIT bleeding, intestinal obstruction and/or diarrhoea. [4] KS is confirmed by histopathological examination of biopsy specimens and with relevant ancillary investigations such as HHV8 latency-associated nuclear antigen 1 (LNA-1) immunohistochemistry (IHC). The typical histopathological features encompass a spindle cell proliferation with formation of slit-like vascular spaces, extravasated red bood cells (Fig. 1) , haemosiderin pigment, plasma cells and hyaline globules. Three histological stages, patch, plaque and nodular, are recognised based on the clinical appearance and increasing degree of spindle cell proliferation. Furthermore, special morphological variants of KS have been described, e.g. lymphangiomatous, lymphangiectatic, telangiectatic and keloidal variants among others. [5] Despite the huge burden of disease in resource-limited settings, application of appropriate treatment options is possible and effective. Treatment options for AIDS-related KS include antiretroviral therapy (ART), local treatment, cytotoxic chemotherapy and targeted agents. [6] The disease burden of KS in SSA is enormous. It is diagnosed on a daily basis at Chris Hani Baragwanath Academic Hospital (CHBAH), Johannesburg, South Africa (SA), yet published data from this hospital are lacking. The purpose of this study is to address some of the deficiencies in the literature as it pertains to patients at CHBAH, the largest hospital in the southern hemisphere.
Methods
An observational retrospective crosssectional study design was used. 
Results
In total, 938 biopsies from 901 patients were recorded. The male/female ratio was 1.2:1 (488 males and 412 females). Gender was unknown/unspecified in one patient.
Seven hundred and thirty-one patients (81.1% of the total number) were HIVseropositive and 9 were HIV-seronegative as confirmed by HIV enzyme-linked immunosorbent assay (ELISA). HIV status was unknown in 161 (17.9%) cases. There were 396 HIV-seropositive males and 334 HIV-seropositive females (male/female ratio 1.2:1).
The mean (standard deviation (SD)) age at biopsy diagnosis of KS for the entire cohort was 36.8 (10.2) years, and 36.4 (9.7) years in the confirmed HIV-seropositive subgroup. The mean age for confirmed HIVseropositive males and females was 38.1 (9.3) and 34.5 (9.7) years, respectively.
Age was unspecified, and therefore not recorded, in 12 patients.
The median CD4 count recorded within 1 month of confirmed KS was 127.5 (quartile range (QR) 184.5) cells/µL and the mean (SD) was 155.74 (143.58) cells/µL (n=540). Three hundred and eighty-two patients had CD4 counts <200 cells/µL, 127 had counts between 200 and 400 cells/µL, and 27 had counts between 400 and 600 cells/ µL. HIV-seropositive males had a median CD4 count of 130 (QR 127.7) cells/ µL and HIV-seropositive females had a median CD4 count of 120.5 (QR 181.0) cells/µL.
Topographic sites were clinically un specified in 264 biopsies. The majority of biopsies (where site was specified) were from the skin (81.5%). One case involved the breast and showed spindle cells in filtrating among terminal duct lobular units. HHV8 IHC performed on this case was positive. Thirteen cases of visceral KS were identified, predominantly within the GIT (Table 1) . HHV8 LNA-1 IHC stains were applied to 289 biopsies, 93.8% of which were positive.
Thirteen cases of paediatric KS were identified from 7 males and 6 females (male/female ratio 1.2:1). The mean (SD) age in the paediatric group was 6.5 (3.4) years. HIV status was unknown in 2 paediatric patients, was confirmed to be negative in 1 and was positive in 10. Six CD4 counts were available, with a median of 217.0 (QR 204.0) cells/µL. Lymph nodes (n=5) were the most frequently represented topographic site in this subgroup. Other sites included palate (1), small bowel (1), skin of upper limb (1) and lower limb (2), and foreskin (2) .
Twelve biopsies of KS from 9 HIV ELISA-seronegative patients (1 child and 8 adults) were seen. There was no history of transplantation in these patients. The male/female ratio was 1.3:1, the mean (SD) age was 55.4 (19.7) years, and the commonest site biopsied was skin of the lower limb.
Stages of KS were recorded in the histopathology reports of 708 biopsies. One hundred and nine cases (15.4%) were of patch stage, 380 (53.7%) were of plaque stage and 219 (30.9%) showed nodular-stage KS. Special morphological variants were recorded in 17 cases. Eleven lymphangiomatous (Fig. 2) , 1 telangiectatic and 5 lymphangiectatic variants were documented. Special morphological variants were most frequently noted in lower-limb skin biopsy specimens (41.2%).
Concomitant pathological features were recorded in 4.6% of all biopsies, with infections constituting 27.9% of the additional pathology noted (Table 2) . Seven cases of granulomatous inflammation and KS were seen in the same biopsy specimen. Five were recorded in skin punch biopsies, 1 from a lymph node and an additional case from the breast. Periodic acidSchiff and Ziehl-Neelsen special stains performed on all 7 cases were negative for micro-organisms. Polymerase chain reaction (PCR) for Mycobacterium genus was positive in 1 case of cutaneous KS which had concomitant granulomatous inflammation. Furthermore, acid-fast bacilli were detected in the sputum of an additional patient who had synchronous cutaneous KS and granulomatous inflammation. The features in two skin punch biopsies raised the possibility of concomitant syphilis owing to the presence of a dense lymphoplasmacytic infiltrate. In one case, Warthin-Starry special stain to detect spirochaetes was negative and serological confirmation was advised. Three cases of concomitant candidiasis were recorded in oral cavity biopsies. There were 27 cases of nodal KS, 12 of which showed concomitant pathology. One of these showed granulomatous 
Discussion
Of the tens of thousands of cases of KS diagnosed worldwide, the vast majority are believed to have occurred in SSA. [2] While developed countries are experiencing a decline in the incidence of KS as a result of timeous ART initiation, KS remains a cause of significant morbidity and mortality in developing countries like SA owing to suboptimal availability of ART. [7] SSA is home to approximately 80% of the world's HIV-infected female population, and heterosexual transmission of HIV remains the main mode of spread worldwide. [8] In SA, the risk of developing KS is related to the transmission pattern of HIV, which is predominantly heterosexual. [9] The male/ female ratio of patients diagnosed with confirmed HIV-associated KS in this study is in keeping with the trend of KS shifting from a male-predominant disease [10] and is reflective of the high prevalence of HIV among young women, who bear the brunt of HIV in SA. This is in contrast to the initial recognition of KS as a male-predominant disease in homosexual men in the USA in the 1980s.
The mean age of patients diagnosed with KS at CHBAH was similar to the findings of Mosam et al. [9] and may change as the longterm effects of the ART roll-out programme begin to emerge. It is predicted that with ART, HIV-seropositive patients will live longer and may therefore present later with KS. [11] The mean and median CD4 counts we have demonstrated are lower than those documented in comparable studies. [9] Interestingly, 28.5% of the 540 patients with known CD4 counts had values in excess of 200 cells/µL. This is in keeping with the suggestion that in Africa severe immunosuppression is not a prerequisite for the development of KS. [12] KS most commonly involves mucocutaneous topographic regions. [3] Our study is supportive of this, as at least 63.5% of all KS biopsies at CHBAH during the study period originated from mucocutaneous sites. The limited number of visceral KS may be attributed to under-sampling, as synchronous, more easily accessible mucocutaneous lesions in these patients may have been biopsied instead. KS involving topographic sites considered unusual by Pantanowitz and Dezube [13] in this study included 2 cases in the larynx, 9 in conjunctiva and 1 in the breast.
HIV status was not available in 17.9% of patients. This may be attributed to a number of reasons, including patients refusing consent for HIV testing, HIV testing at a peripheral hospital not linked to the DISA database at CHBAH, failure to recommend HIV testing or failure to specify the patients' status in the clinical history section of the laboratory requisition form.
Pitche et al., [14] in a study of 20 cases of African/endemic KS, found a male/female ratio of 9:1 in contrast to the lower male/ female ratio of patients with endemic KS at CHBAH of 1.3:1.
Interestingly, HHV8 LNA-1 staining was only applied to 30.8% of biopsies at CHBAH during the study period. This reflects variable individual pathologists' practice, as in the appropriate clinical context the histopathological diagnosis may be based on the presence of typical morphological features of KS. In SA's public health sector, immunohistochemistry-related cost factors also play an influential role. In this study, the majority (93.8%) of HHV8 LNA-1 immunohistochemical stains performed on KS biopsies were positive, more than the 64% positivity recorded by Ramos da Silva et al. [15] HHV8 PCR testing may be indicated in those cases displaying clinical and morphological features of KS but negative HHV8 immunohistochemical staining. Paediatric KS (diagnosed in patients aged <14 years) accounted for 1.4% of all biopsies and lymph nodes (n=5) were the most frequent site represented. The findings of Stefan et al. [16] revealed a median age of 6 years, similar to our findings of a median of 7 years. However, their average CD4 count was higher (mean 440 cells/µL v. 209.2 cells/µL in our study), and the most commonly affected site was the skin. Further studies to determine the incidence of paediatric KS may be useful in light of the rigorous prevention of mother-tochild transmission antiretroviral programme, as the impact of reduced vertical transmission of HIV infection may result in a decline in the incidence of KS in children.
In this study, patch-stage KS was diagnosed least frequently of the three histological KS stages. Patch-stage KS may be a subtle manifestation clinically. It is probable that patients are more likely to recognise and be concerned about well-established and/ or larger lesions. Moreover, from a clinical viewpoint, larger lesions are likely to be more representative and provide greater diagnostic/confirmatory yield. Plaque-and nodular-stage KS lesions are therefore more frequently targeted for biopsy.
Granulomatous inflammation was seen in 7 of our specimens, with 2 cases of confirmed Mycobacterium infection. As highlighted by Ramdial et al., [17] adequate investigation of granulomatous inflammation for confirmation of concomitant M. tuberculosis is crucial in highlighting possible multidrug resistance and non-compliance. The review article by Grayson [18] addressed concomitant pathology in cutaneous KS. Our CHBAHbased study documents concomitant pathology occurring in extracutaneous KS biopsy specimens. As concomitant pathology was noted in approxi mately half of all 
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Fig. 2. Lymphangiomatous variant of KS (H&E × 100).
KS-containing lymph node biopsy specimens, reporting pathologists should be vigilant. Treatment options for AIDS-related KS include ART, local treatment (radiation, topical agents), cytotoxic chemotherapy and targeted agents. KS lesions regress with initiation of ART. ART inhibits HIV replication, decreases production of HIV-tat and ameliorates the immune response to HHV8. [6] Semeere et al. [7] demonstrated a reduction in the incidence of KS by 72% in ART users compared with non-ART users. These findings were corroborated by Bohlius et al., [19] who concluded that the most effective treatment modality remains ART, as it significantly decreases morbidity and mortality. ART may be associated with immune reconstitution syndrome (IRIS). KS-IRIS has been well documented. Recently, it has been shown that the incidence of KS-IRIS is higher in Africa than in the UK, with 13.9% of individuals developing KS-IRIS, a rate 2.5 times higher than European cohorts. [20] Chemotherapy which includes anthracyclines is used for treatment of visceral disease and progressive mucocutaneous lesions. Local therapy such as radiotherapy is useful for palliation, management of bulky lesions and cosmesis. In this era of molecular medicine, targeted pathogenesis-based treatments such as antiangiogenic compounds, retinoic acid, hormonal agents and antiherpes agents are also being used in the treatment of KS. [6] 
Study limitations
A possible limitation of this study is that there was an element of sampling bias, as CHBAH is a tertiary hospital. Patients treated at this hospital are likely to have a greater burden of disease (i.e. lower CD4 counts and more advanced HIV infection) than those treated at local clinics. Clinical data regarding ART use were not available.
Conclusion
KS is a pathogenetically and morphologically diverse disease. The epidemiology has changed dramatically since AIDS-associated KS was first diagnosed in the 1980s. With the introduction of ART, the demographics may shift once again as the effects of therapy become apparent. In conclusion, this study highlights the clinicopathological aspects and burden of HIV-associated KS at CHBAH and includes limited representation of endemic, paediatric and visceral KS subgroups. The histopathological spectrum of KS, including special morphological variants, and presence of concomitant pathology have also been reported. The findings of this study serve as a foundation on which further comparative research could be based.
